[BIIB] Biogen Inc.


Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 287.53 Change: 4.46 (1.58%)
Ext. hours: 292.98 Change: 5.45 (1.9%)

chart BIIB

Refresh chart

Strongest Trends Summary For BIIB

BIIB is in the long-term up 498% in 21 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of multiple sclerosis (MS), neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. It provides AVONEX to treat relapsing MS; TYSABRI to treat relapsing forms of MS and Crohn?s disease; RITUXAN for treating relapsed or refractory, follicular, CD20-positive, and B-cell Non-Hodgkin?s lymphoma (NHL); FUMADERM to treat severe plaque psoriasis in adult patients; FAMPYRA, an oral compound for the improvement of walking in adult patients with MS; TECFIDERA for the treatment of MS; and GAZYVA, an injection for intravenous infusion that treats an untreated chronic lymphocytic leukemia. The company?s products that completed Phase III clinical trials comprise ELOCTATE and ALPROLIX, an inherited disorder that inhibits blood coagulations; and Peginterferon beta-1a to prolong the effects and reduce the dosing frequency of interferon beta-1a. Its products under Phase III clinical tri

Fundamental Ratios
Shares Outstanding EPS17.73 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 3.19% Sales Growth - Q/Q1.44% P/E14.2
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA20.83% ROE27.76% ROI24.82%
Current Ratio2.2 Quick Ratio1.86 Long Term Debt/Equity0.19 Debt Ratio0.2
Gross Margin88.36% Operating Margin45.28% Net Profit Margin33.89% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities77.22 M Cash From Investing Activities-1.76 B Cash From Operating Activities1.78 B Gross Profit2.31 B
Net Profit927.28 M Operating Profit1.23 B Total Assets16.76 B Total Current Assets5.62 B
Total Current Liabilities2.56 B Total Debt579.47 M Total Liabilities4.19 B Total Revenue2.59 B
Technical Data
High 52 week383.83 Low 52 week219.29 Last close235.8 Last change-1.02%
RSI53.32 Average true range6.6 Beta1.03 Volume1.07 M
Simple moving average 20 days-0.53% Simple moving average 50 days0.76% Simple moving average 200 days-10.8%
Performance Data
Performance Week-2.67% Performance Month1.81% Performance Quart4.23% Performance Half-22.99%
Performance Year-27.62% Performance Year-to-date-30.73% Volatility daily1.64% Volatility weekly3.66%
Volatility monthly7.5% Volatility yearly25.97% Relative Volume178.46% Average Volume1.55 M
New High New Low


2020-05-29 08:47:12 | Veeva Systems VEEV Q1 Earnings and Revenues Beat Estimates

2020-05-29 08:00:10 | Vir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 Treatment

2020-05-28 07:30:10 | Biogen and MIT Launch New Virtual Learning Lab for High School Students Historically Underrepresented in Science

2020-05-26 12:55:17 | Hedge Funds Are Betting On Biogen Inc. BIIB

2020-05-26 06:44:55 | An Intrinsic Calculation For Biogen Inc. NASDAQ:BIIB Suggests It's 24% Undervalued

2020-05-26 05:37:09 | Veeva Systems VEEV to Post Q1 Earnings: What's in Store?

2020-05-23 07:36:00 | Better Buy: Biogen vs. Axsome Therapeutics

2020-05-22 18:04:26 | Richard Snow Buys Into Tyson and Reduces Dow in 1st Quarter

2020-05-22 09:05:53 | 7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine

2020-05-22 06:07:10 | Medtronic MDT Q4 Earnings Miss Estimates, Revenues Beat

2020-05-20 09:23:00 | Here are the ‘hot dogs’ that hedge funds have used to outperform this year

2020-05-20 09:03:01 | McKesson MCK Q4 Earnings and Revenues Surpass Estimates

2020-05-20 08:58:12 | Zacks.com featured highlights include: Graphic Packaging, Canadian Solar, Biogen and Vistra Energy

2020-05-19 09:48:01 | 4 Low Price-to-Book Value Stocks to Buy in May

2020-05-19 07:30:10 | New Data at AAN Showcase Biogen’s Commitment to Advancing Innovation in MS

2020-05-18 14:47:12 | Moderna COVID-19 vaccine data is ‘baby-step’ in right direction: Expert

2020-05-18 07:30:10 | New SPINRAZA® nusinersen Data Reinforce Sustained Efficacy and Longer-Term Safety Across Broad Range of Spinal Muscular Atrophy SMA Patients

2020-05-15 10:18:02 | STERIS' STE Q4 Earnings Surpass Estimates, Margins Rise

2020-05-14 10:00:02 | GNC Holdings' GNC Q1 Earnings and Sales Miss Estimates

2020-05-14 09:34:01 | AMN Healthcare AMN Q1 Earnings In Line With Estimates

2020-05-14 09:28:01 | Intersect ENT XENT Reports Wider-Than-Expected Q1 Loss

2020-05-13 13:16:24 | 6 Stocks John Hussman Continues to Buy

2020-05-13 10:09:02 | Phibro PAHC Q3 Earnings Surpass Estimates, Margin Declines

2020-05-13 10:05:02 | HMS Holdings HMSY Earnings and Revenues Beat Estimates in Q1

2020-05-12 16:01:10 | Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results

2020-05-12 10:03:02 | Allscripts MDRX Q1 Earnings and Revenues Miss Estimates

2020-05-12 10:00:02 | National Vision EYE Q1 Earnings Top Estimates, Margin Falls

2020-05-12 08:51:12 | Integer Holdings ITGR Q1 Earnings & Revenues Top Estimates

2020-05-11 17:40:04 | US Indexes Post Some Gains Monday

2020-05-11 11:58:03 | Zimmer Biomet ZBH Q1 Earnings Top, Revenues Miss Estimates

2020-05-11 10:39:02 | Insulet PODD Q1 Earnings Lag Estimates, Margins Decline

2020-05-11 10:26:02 | Fresenius Medical FMS Q1 Earnings Miss Estimates, Fall Y/Y

2020-05-11 10:07:02 | Cardinal Health CAH Beats Q3 Earnings and Revenue Estimates

2020-05-11 09:52:01 | LHC Group LHCG Earnings and Revenues Beat Estimates in Q1

2020-05-08 10:33:02 | OPKO Health OPK Reports Q1 Loss, Lags Revenue Estimates

2020-05-08 08:59:12 | Avanos Medical AVNS Q1 Earnings Lag Estimates, Revenues Top

2020-05-08 08:51:12 | DENTSPLY SIRONA XRAY Posts Weak Q1 Preliminary Results

2020-05-08 08:50:12 | Integra IART Lags Q1 Earnings Estimates, Withdraws Outlook

2020-05-08 08:50:12 | Glaukos GKOS Q1 Earnings and Revenues Miss Estimates

2020-05-08 08:46:12 | Bruker BRKR Q1 Earnings Miss Estimates, Guidance Suspended

2020-05-08 07:57:11 | Pacific Biosciences PACB Q1 Earnings Surpass Estimates

2020-05-07 15:28:43 | Nasdaq Stock Exchange president on IPO outlook amid COVID-19

2020-05-07 11:03:03 | Amedisys AMED Q1 Earnings Beat, Operating Margin Falls

2020-05-07 10:40:02 | QIAGEN QGEN Q1 Earnings Lag Estimates, Operating Margin Up

2020-05-07 10:33:02 | AmerisourceBergen ABC Q2 Earnings & Revenues Top Estimates

2020-05-07 10:11:02 | Bio-Rad BIO Beats Q1 Earnings Estimates, Withdraws View

2020-05-07 10:09:02 | Exact Sciences' EXAS Q1 Earnings Fall Y/Y, Margin Expands

2020-05-07 09:14:01 | Nevro NVRO Earnings and Revenues Beat Estimates in Q1

2020-05-07 09:09:01 | Becton Dickinson BDX Q2 Earnings and Revenues Top Estimates

2020-05-06 11:49:03 | Myriad Genetics MYGN Lags Q3 Earnings Estimates, Cancels View